Feliqs

Developer of therapuetics for ophthalmic, neurological, and neonatal diseases

placeKurume, Fukuoka, Japan calendar_todayFounded 2019 language feliqs.com

Social engagement

Social engagement: 541 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Beyond Next Ventures.

Investor typeCountShare
Venture capital360%
Private equity120%
Other / undisclosed120%

Recent activity

1 Jun 2026
Event
Yokohama LINK-J Life Science Lounge NYC Meetup 2026: Bridging the U.S. and Japan Life Science Ecosystems
21 Dec 2025
Milestone
regulatory
18 Nov 2025
Event
OIS XV
Coming soon